Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

AMS:TOM2 - Euronext Amsterdam - NL0013332471 - Common Stock - Currency: EUR

4.643  +0.04 (+0.93%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TOM2. TOM2 was compared to 97 industry peers in the Software industry. While TOM2 seems to be doing ok healthwise, there are quite some concerns on its profitability. TOM2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TOM2 had negative earnings in the past year.
In the past year TOM2 had a positive cash flow from operations.
TOM2 had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TOM2 reported negative operating cash flow in multiple years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

TOM2 has a Return On Assets of -1.30%. This is in the lower half of the industry: TOM2 underperforms 60.82% of its industry peers.
Looking at the Return On Equity, with a value of -6.58%, TOM2 is doing worse than 61.86% of the companies in the same industry.
Industry RankSector Rank
ROA -1.3%
ROE -6.58%
ROIC N/A
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With an excellent Gross Margin value of 85.20%, TOM2 belongs to the best of the industry, outperforming 83.51% of the companies in the same industry.
In the last couple of years the Gross Margin of TOM2 has grown nicely.
TOM2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

TOM2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
TOM2 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TOM2 has less shares outstanding
Compared to 1 year ago, TOM2 has a worse debt to assets ratio.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

TOM2 has a debt to FCF ratio of 18.57. This is a negative value and a sign of low solvency as TOM2 would need 18.57 years to pay back of all of its debts.
TOM2's Debt to FCF ratio of 18.57 is in line compared to the rest of the industry. TOM2 outperforms 44.33% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that TOM2 is not too dependend on debt financing.
TOM2's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. TOM2 outperforms 65.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 18.57
Altman-Z N/A
ROIC/WACCN/A
WACC7.82%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

TOM2 has a Current Ratio of 1.76. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TOM2 (1.76) is better than 71.13% of its industry peers.
A Quick Ratio of 1.71 indicates that TOM2 should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.71, TOM2 is doing good in the industry, outperforming 72.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.71
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

TOM2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.19%, which is quite impressive.
Looking at the last year, TOM2 shows a decrease in Revenue. The Revenue has decreased by -1.34% in the last year.
The Revenue has been decreasing by -3.90% on average over the past years.
EPS 1Y (TTM)63.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%0.8%

3.2 Future

Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 57.79% on average per year.
Based on estimates for the next years, TOM2 will show a small growth in Revenue. The Revenue will grow by 7.40% on average per year.
EPS Next Y-55.36%
EPS Next 2Y115.06%
EPS Next 3Y57.79%
EPS Next 5YN/A
Revenue Next Year-4.71%
Revenue Next 2Y0.02%
Revenue Next 3Y2.42%
Revenue Next 5Y7.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

TOM2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 18.58 indicates a rather expensive valuation of TOM2.
Based on the Price/Forward Earnings ratio, TOM2 is valued a bit cheaper than the industry average as 75.26% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of TOM2 to the average of the S&P500 Index (20.35), we can say TOM2 is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 18.58
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOM2 is valued cheaper than 85.57% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as TOM2.
Industry RankSector Rank
P/FCF 260.37
EV/EBITDA 7.35
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

TOM2's earnings are expected to grow with 57.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115.06%
EPS Next 3Y57.79%

More info and screens

0

5. Dividend

5.1 Amount

TOM2 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOMTOM NV

AMS:TOM2 (5/7/2025, 5:29:53 PM)

4.643

+0.04 (+0.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15/bmo
Earnings (Next)07-15 2025-07-15
Inst Owners22.75%
Inst Owner ChangeN/A
Ins Owners53.12%
Ins Owner ChangeN/A
Market Cap580.38M
Analysts45
Price Target5.36 (15.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.63%
Min Revenue beat(2)3.11%
Max Revenue beat(2)4.14%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)4.14%
Revenue beat(8)4
Avg Revenue beat(8)0.3%
Revenue beat(12)7
Avg Revenue beat(12)2.97%
Revenue beat(16)7
Avg Revenue beat(16)1.12%
PT rev (1m)-3.23%
PT rev (3m)-18.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-286.67%
EPS NY rev (3m)-261.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.62%
Revenue NY rev (3m)-9.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.58
P/S 1.01
P/FCF 260.37
P/OCF 37.05
P/B 4.06
P/tB N/A
EV/EBITDA 7.35
EPS(TTM)-0.09
EYN/A
EPS(NY)0.25
Fwd EY5.38%
FCF(TTM)0.02
FCFY0.38%
OCF(TTM)0.13
OCFY2.7%
SpS4.6
BVpS1.14
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.3%
ROE -6.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.2%
FCFM 0.39%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 18.57
Debt/EBITDA 1.48
Cap/Depr 42.98%
Cap/Sales 2.33%
Interest Coverage N/A
Cash Conversion 72.51%
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.71
Altman-Z N/A
F-Score8
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y-55.36%
EPS Next 2Y115.06%
EPS Next 3Y57.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.34%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%0.8%
Revenue Next Year-4.71%
Revenue Next 2Y0.02%
Revenue Next 3Y2.42%
Revenue Next 5Y7.4%
EBIT growth 1Y64.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.48%
EBIT Next 3Y75.75%
EBIT Next 5YN/A
FCF growth 1Y118.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y334.96%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%